ArticleObesity (Silver Spring, Md.)2025

Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status.

Hamlet Gasoyan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.